Cordatus Wealth Management LLC cut its stake in Aflac Incorporated (NYSE:AFL – Free Report) by 58.0% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 11,797 shares of the financial services provider’s stock after selling 16,288 shares during the period. Cordatus Wealth Management LLC’s holdings in Aflac were worth $1,318,000 as of its most recent SEC filing.
Several other hedge funds also recently made changes to their positions in the company. Duncan Williams Asset Management LLC increased its position in shares of Aflac by 5.0% during the second quarter. Duncan Williams Asset Management LLC now owns 2,065 shares of the financial services provider’s stock worth $218,000 after purchasing an additional 98 shares in the last quarter. Dynamic Advisor Solutions LLC grew its stake in Aflac by 5.1% during the 3rd quarter. Dynamic Advisor Solutions LLC now owns 2,037 shares of the financial services provider’s stock worth $227,000 after buying an additional 99 shares during the last quarter. Stiles Financial Services Inc increased its position in Aflac by 3.4% during the second quarter. Stiles Financial Services Inc now owns 3,070 shares of the financial services provider’s stock worth $324,000 after buying an additional 100 shares during the period. Smith Moore & CO. lifted its stake in Aflac by 1.7% in the second quarter. Smith Moore & CO. now owns 6,143 shares of the financial services provider’s stock valued at $648,000 after buying an additional 100 shares during the last quarter. Finally, Relyea Zuckerberg Hanson LLC boosted its holdings in shares of Aflac by 2.5% in the second quarter. Relyea Zuckerberg Hanson LLC now owns 4,408 shares of the financial services provider’s stock valued at $465,000 after acquiring an additional 107 shares during the period. Hedge funds and other institutional investors own 67.44% of the company’s stock.
Wall Street Analyst Weigh In
Several brokerages have issued reports on AFL. Wells Fargo & Company raised their price objective on shares of Aflac from $107.00 to $109.00 and gave the stock an “equal weight” rating in a research report on Friday, November 7th. Cowen reissued a “hold” rating on shares of Aflac in a report on Monday, December 22nd. TD Cowen boosted their price target on Aflac from $100.00 to $102.00 and gave the company a “hold” rating in a research report on Monday, December 22nd. Piper Sandler set a $125.00 price objective on Aflac and gave the stock an “overweight” rating in a research report on Tuesday, October 7th. Finally, JPMorgan Chase & Co. lifted their target price on Aflac from $101.00 to $105.00 and gave the company a “neutral” rating in a research note on Monday. Three investment analysts have rated the stock with a Buy rating, eight have issued a Hold rating and three have issued a Sell rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $110.92.
Insider Activity
In related news, Director Joseph L. Moskowitz sold 1,000 shares of the firm’s stock in a transaction that occurred on Friday, November 7th. The shares were sold at an average price of $114.00, for a total value of $114,000.00. Following the sale, the director directly owned 23,615 shares of the company’s stock, valued at approximately $2,692,110. This trade represents a 4.06% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Steven Kent Beaver sold 5,492 shares of the stock in a transaction on Friday, December 12th. The stock was sold at an average price of $109.53, for a total value of $601,538.76. Following the completion of the transaction, the executive vice president directly owned 38,368 shares in the company, valued at $4,202,447.04. This trade represents a 12.52% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last ninety days, insiders sold 31,766 shares of company stock worth $3,549,706. 0.90% of the stock is currently owned by corporate insiders.
Aflac Price Performance
Shares of NYSE:AFL opened at $112.11 on Tuesday. Aflac Incorporated has a 52 week low of $96.95 and a 52 week high of $115.83. The company has a 50-day moving average price of $110.33 and a 200 day moving average price of $107.50. The company has a market cap of $58.76 billion, a P/E ratio of 14.64, a PEG ratio of 3.23 and a beta of 0.67. The company has a quick ratio of 0.11, a current ratio of 0.11 and a debt-to-equity ratio of 0.30.
Aflac (NYSE:AFL – Get Free Report) last released its earnings results on Monday, February 27th. The financial services provider reported $1.07 EPS for the quarter. Aflac had a return on equity of 14.97% and a net margin of 23.55%.The company had revenue of $5.91 billion during the quarter. Research analysts predict that Aflac Incorporated will post 6.88 earnings per share for the current year.
Aflac Increases Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Monday, March 2nd. Investors of record on Wednesday, February 18th will be paid a dividend of $0.61 per share. The ex-dividend date of this dividend is Wednesday, February 18th. This is an increase from Aflac’s previous quarterly dividend of $0.58. This represents a $2.44 dividend on an annualized basis and a dividend yield of 2.2%. Aflac’s dividend payout ratio is 31.85%.
About Aflac
Aflac Incorporated (American Family Life Assurance Company of Columbus) is a provider of supplemental insurance products designed to help policyholders manage out-of-pocket health care and living expenses. The company underwrites a range of individual and group policies that typically pay cash benefits directly to insureds when covered events occur, enabling greater financial flexibility for medical treatment, hospital stays, critical illness, and related costs. Aflac’s product mix includes supplemental health insurance, life insurance and other specialty coverages intended to complement primary medical plans.
Founded in the mid-20th century and headquartered in Columbus, Georgia, Aflac distributes its products through a combination of employer-sponsored programs, independent brokers and agents, and direct marketing.
Further Reading
- Five stocks we like better than Aflac
- A month before the crash
- BNZI: BNZI Surges Ahead as AI Marketing Fuels Record Revenue
- A U.S. “birthright” claim worth trillions – activated quietly
- A Message From An Ex-CIA Officer About Trump
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
Want to see what other hedge funds are holding AFL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aflac Incorporated (NYSE:AFL – Free Report).
Receive News & Ratings for Aflac Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aflac and related companies with MarketBeat.com's FREE daily email newsletter.
